22 results Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court. Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act. Stibbe represents Swiss Life Stibbe represented Swiss Life before the criminal courts of Antwerp in a case in which it is charged with issuing "Tak 23" investment products that are financed by means of an allegedly illegal system of mortgage loans. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises ONDD Stibbe assisted the ONDD (Office national du ducroire - Nationale Delcrederedienst) in arbitral proceedings—and obtaining a favourable ruling for it—regarding insurance claims arising out of the early termination of construction contracts in Dubai. Stibbe represents aviation client Stibbe represented an aviation client before a Belgian criminal court in a liability case relating to the fire in a hangar at the Belgian National Airport. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Stibbe advises European leading television format supplier Stibbe assisted a European leading television format supplier in various legal aspects of TV phone-in games. Stibbe represented several clients in an EU inquiry on alleged forgery and public procurement cases Stibbe assisted clients from a range of sectors in an inquiry conducted by the Anti-Fraud Office of the European Union concerning alleged forgery and public procurement cases within the EU. Stibbe assists major telecom operator Stibbe assisted a major telecom operator with a large-scale cyber attack on its company systems. Pagination Current page 1 Page 2 Next page
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court.
Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act.
Stibbe represents Swiss Life Stibbe represented Swiss Life before the criminal courts of Antwerp in a case in which it is charged with issuing "Tak 23" investment products that are financed by means of an allegedly illegal system of mortgage loans.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises ONDD Stibbe assisted the ONDD (Office national du ducroire - Nationale Delcrederedienst) in arbitral proceedings—and obtaining a favourable ruling for it—regarding insurance claims arising out of the early termination of construction contracts in Dubai.
Stibbe represents aviation client Stibbe represented an aviation client before a Belgian criminal court in a liability case relating to the fire in a hangar at the Belgian National Airport.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Stibbe advises European leading television format supplier Stibbe assisted a European leading television format supplier in various legal aspects of TV phone-in games.
Stibbe represented several clients in an EU inquiry on alleged forgery and public procurement cases Stibbe assisted clients from a range of sectors in an inquiry conducted by the Anti-Fraud Office of the European Union concerning alleged forgery and public procurement cases within the EU.
Stibbe assists major telecom operator Stibbe assisted a major telecom operator with a large-scale cyber attack on its company systems.